Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Themis Medicare Limited ( (IN:THEMISMED) ) has provided an update.
Themis Medicare Limited has initiated a postal ballot process, conducted exclusively through remote e-voting, to seek shareholder approval for ordinary and special resolutions in line with the Companies Act and SEBI listing regulations. The notice, sent electronically to eligible shareholders with registered email addresses, outlines that voting will be facilitated by CDSL between 26 February and 27 March 2026, with results to be declared on or before 31 March 2026, underscoring the company’s reliance on digital mechanisms and statutory compliance for shareholder decision-making.
The company is leveraging MCA circulars that permit electronic-only dispatch and voting, ensuring participation without physical meetings and aligning with contemporary corporate governance practices. By formalizing this process via stock exchange intimation and hosting the notice on its website, Themis Medicare reinforces transparency for investors and provides a clear framework for exercising voting rights based on paid-up share value as of the specified cut-off date.
More about Themis Medicare Limited
Themis Medicare Limited is an India-based pharmaceutical company operating from corporate offices in Mumbai and a registered office in Vapi, Gujarat. The company is listed on both BSE and the National Stock Exchange, reflecting its presence in the public capital markets and focus on regulated corporate governance and disclosure norms.
Average Trading Volume: 8,342
Technical Sentiment Signal: Sell
Current Market Cap: 7.87B INR
For an in-depth examination of THEMISMED stock, go to TipRanks’ Overview page.